Gigi Georgiana Huang

Array ( [id] => 15099467 [patent_doc_number] => 10471027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-12 [patent_title] => Pharmacology of visual cycle modulators [patent_app_type] => utility [patent_app_number] => 12/830155 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14241 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12830155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026568 [patent_doc_number] => 20110054029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'WATER-SOLUBLE DIETARY FATTY ACIDS' [patent_app_type] => utility [patent_app_number] => 12/823945 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8349 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054029.pdf [firstpage_image] =>[orig_patent_app_number] => 12823945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8269948 [patent_doc_number] => 08211450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Ophthalmic composition' [patent_app_type] => utility [patent_app_number] => 12/774419 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9038 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12774419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616977 [patent_doc_number] => 20100310642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Topical Drug Delivery Systems for Ophthalmic Use' [patent_app_type] => utility [patent_app_number] => 12/774600 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310642.pdf [firstpage_image] =>[orig_patent_app_number] => 12774600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043445 [patent_doc_number] => 20120071448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'S1P3 Receptor Inhibitors for Treating Conditions of the Eye' [patent_app_type] => utility [patent_app_number] => 13/318583 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17018 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071448.pdf [firstpage_image] =>[orig_patent_app_number] => 13318583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184108 [patent_doc_number] => 20120114637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'MTOR PATHWAY INHIBITORS FOR TREATING OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/265530 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 107627 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114637.pdf [firstpage_image] =>[orig_patent_app_number] => 13265530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173949 [patent_doc_number] => 20120108665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/318770 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10656 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108665.pdf [firstpage_image] =>[orig_patent_app_number] => 13318770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6578225 [patent_doc_number] => 20100273892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES' [patent_app_type] => utility [patent_app_number] => 12/768554 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21444 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273892.pdf [firstpage_image] =>[orig_patent_app_number] => 12768554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591428 [patent_doc_number] => 08349303 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-01-08 [patent_title] => 'Polymeric quaternium compounds' [patent_app_type] => utility [patent_app_number] => 12/758860 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9812 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12758860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141341 [patent_doc_number] => 20120095215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF EYE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/262531 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28587 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095215.pdf [firstpage_image] =>[orig_patent_app_number] => 13262531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6395218 [patent_doc_number] => 20100178265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'HAIR CONDITIONING COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/728551 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5461 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178265.pdf [firstpage_image] =>[orig_patent_app_number] => 12728551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670194 [patent_doc_number] => 20110319463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'PREVENTIVE OR THERAPEUTIC AGENTS FOR OPTIC NERVE DISORDERS COMPRISING 4,6-DICHLORO-1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AS ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/255563 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6671 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636638 [patent_doc_number] => 20100226981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A GABAPENTIN PRODRUG' [patent_app_type] => utility [patent_app_number] => 12/718857 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16295 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226981.pdf [firstpage_image] =>[orig_patent_app_number] => 12718857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10888240 [patent_doc_number] => 08912236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye' [patent_app_type] => utility [patent_app_number] => 12/716624 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3907 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12716624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056207 [patent_doc_number] => 20120077836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO [G] QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/202590 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25166 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077836.pdf [firstpage_image] =>[orig_patent_app_number] => 13202590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6501512 [patent_doc_number] => 20100215743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Composition and drug delivery of bisphosphonates' [patent_app_type] => utility [patent_app_number] => 12/712527 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12575 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215743.pdf [firstpage_image] =>[orig_patent_app_number] => 12712527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6421197 [patent_doc_number] => 20100150992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Methods for Treatment of Ophthalmic Disease of an External Ophthalmic Tissue' [patent_app_type] => utility [patent_app_number] => 12/712459 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11410 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150992.pdf [firstpage_image] =>[orig_patent_app_number] => 12712459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17921560 [patent_doc_number] => 11464781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => PDE1 inhibitors for ophthalmic disorders [patent_app_type] => utility [patent_app_number] => 13/203365 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11455 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6517208 [patent_doc_number] => 20100216877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Storage Stable Prostaglandin Product' [patent_app_type] => utility [patent_app_number] => 12/707744 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4357 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216877.pdf [firstpage_image] =>[orig_patent_app_number] => 12707744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6520710 [patent_doc_number] => 20100203146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'INTERMITTENT DOSING STRATEGY FOR TREATING RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 12/702697 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4985 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203146.pdf [firstpage_image] =>[orig_patent_app_number] => 12702697 [rel_patent_id] =>[rel_patent_doc_number] =>)